3SOF

BUSINESS SUMMARY  
PURE Bioscience engages in the development and marketing of technology-based bioscience products. It primarily offers silver dihydrogen citrate (SDC), an aqueous antimicrobial technology. SDC is an electrolytically generated source of stabilized ionic silver that would serve as the basis for various products in diverse markets. The company provides Axen30, a hard surface disinfectant to commercial; industrial; and consumer markets, including restaurants, homes, and medical facilities. In addition, the company offers Innovex line of pest control products, including the RoachX; AntX75; nontoxic TrapX rodent lure; and CleanKill, the SDC-based hard surface disinfectant for the pest control industry. PURE Bioscience markets its pest control products to both commercial pest control and consumer products companies. The company was incorporated as Innovative Medical Services in 1992 and changed its name to PURE Bioscience in 2003. PURE Bioscience is headquartered in El Cajon, California.


missed it ...uptrend so pure!!

Nobody like a PURE uptrend?
I posted it 2 weeks ago @ 1.90 ...NOW, it closed today @ 2.57

Prices close above MA50, MA200 & EMA200 long time ago
This is the kind of stock you want to get in when prices closed above those 3 moving averages    goodluck!!

A simple strategy, make good money

Let's get back to PURE, this is a pure breakout!

Nice Terliso.......Applaud !

PURE...Double Bottom (reversal) Pattern...Break Out !
Very nice T/A.......as it moves to take out '06 high.

Support @ $2.89...2.79...2.65
Resistance @ $3.14

52wk Range: 1.26 - 3.14
Volume: 288,586
Avg Vol (3m): 105,041

Technicals
Record Price High
MACD is Bullish
Stochastic is Bullish

Last Price Quote is:
17.71%above 13-day MA
31.79%above 50-day MA
RS Rating: N/A 

Fundamentals
Key Data:
Market Cap (M): $76.56 
P/E Ratio: NA 
PEG Ratio: N/A 
Next Earnings: 06/14/2007
Last Analyst Rating: N/A


Double Bottom (Reversal) Pattern.......

The double bottom is a major reversal pattern that forms after an extended downtrend. As its name implies, the pattern is made up of two consecutive troughs that are roughly equal, with a moderate peak in-between.

Although there can be variations, the classic double bottom usually marks an intermediate or long-term change in trend. Many potential double bottoms can form along the way down, but until key resistance is broken, a reversal cannot be confirmed.

It is important to remember that the double bottom is an intermediate to long-term reversal pattern that will not form in a few days. Even though formation in a few weeks is possible, it is preferable to have at least 4 weeks between lows. Bottoms usually take longer than tops to form and patience can often be a virtue. Give the pattern time to develop and look for the proper clues. The advance off of the first trough should be 10-20%. The second trough should form a low within 3% of the previous low and volume on the ensuing advance should increase. Volume indicators such as Chaikin Money Flow, OBV and Accumulation/Distribution can be used to look for signs of buying pressure. Just as with the double top, it is paramount to wait for the resistance breakout. The formation is not complete until the previous reaction high is taken out.


Below are the 6 Month and 3 Year Charts.......

PURE is onfire again.

Congrats for finding it Terliso are you still holding it ?

A 'Pandemic' Now Declared, Focus Back on Swine Flu Stocks
On Friday June 12, 2009, 12:00 pm EDT

The H1N1 virus is officially a pandemic, and vaccine stocks are responding.

Swine flu stocks are up again today, with some extending weekly gains to more than 20%. A number of companies released good news to end the week. From small-cap players to multi-billion dollar giants, shares are up big on high volume. Novartis (NYSE: NVS) announced today that it will have a swine flu vaccine ready by this fall. Shares are up by 4% on the news.

On Thursday, the World Health Organization raised its alert level on the virus to "Phase 6," indicating that it has officially become a pandemic.

As a whole the Swine Flu and Bird Flu Stocks Index is up by 2.5%. It is now beating the S&P 500 by 35.5% over the last month.

Generex Biotechnology (NASDAQ: GNBT) is leading the Index today with 10% gains. The company was granted five new patents for its drug delivery systems. The patents were awarded in Canada, Australia, New Zealand, Brazil, and Lebanon. The stock is still in negative territory this week by -3%.

Sinovac Biotech (AMEX: SVA) is adding another 3% to its industry-leading 30% weekly rally. On Monday the company announced that it had begun production of a swine flu vaccine, and noted that it could produce up to 30 million doses per year.

Vical (NASDAQ: VICL) has fallen from earlier highs, and is now trading up fractionally. Thomas Weisel initiated coverage of the company today with an Overweight rating and a $5 price target. The analyst cited Vical's proprietary technology, strategic partnerships, and licensing agreements.

GlaxoSmithKline (NYSE: GSK) and Hemispherx Biopharma (AMEX: HEB) are both ahead by more than 4% today.

Pure Bioscience (NASDAQ: PURE) and AVI Biopharma (NASDAQ: AVII) are industry laggards today, falling by -3% and -6% respectively.

As of this writing the Swine Flu and Bird Flu Stocks Index is a top-three performing tickerspy Index over the last month, gaining 39.5%.

Investors can follow the Swine Flu and Bird Flu Stocks Index and view related performance charts and metrics at tickerspy.com.

Investors can follow the Swine Flu and Bird Flu Stocks Index and view related performance charts and metrics at tickerspy.com.
http://www.tickerspy.com/index/Swine-Flu-and-Bird-Flu-Stocks?refer=2028Y3
   

PURE - Breakout
http://finance.yahoo.com/q?s=PURE
Pure Bioscience, Inc. engages in the development and commercialization of bioscience technologies principally in the United States. The company offers silver dihydrogen citrate (SDC) based antimicrobials.